Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biotelemetry Inc (BEAT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,964,121
  • Shares Outstanding, K 32,790
  • Annual Sales, $ 286,780 K
  • Annual Income, $ -15,960 K
  • 36-Month Beta 1.45
  • Price/Sales 7.10
  • Price/Cash Flow 33.16
  • Price/Book 7.45

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.31
  • Number of Estimates 4
  • High Estimate 0.36
  • Low Estimate 0.26
  • Prior Year 0.16
  • Growth Rate Est. (year over year) +93.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
55.60 +10.88%
on 09/13/18
62.80 -1.83%
on 09/14/18
+4.70 (+8.25%)
since 08/17/18
3-Month
43.30 +42.38%
on 06/28/18
62.80 -1.83%
on 09/14/18
+15.25 (+32.87%)
since 06/18/18
52-Week
23.30 +164.59%
on 11/13/17
62.80 -1.83%
on 09/14/18
+30.90 (+100.49%)
since 09/18/17

Most Recent Stories

More News
Biotelemetry Inc Up 82.0% Since SmarTrend Uptrend Call (BEAT)

SmarTrend identified an Uptrend for Biotelemetry Inc (NASDAQ:BEAT) on April 16th, 2018 at $34.18. In approximately 5 months, Biotelemetry Inc has returned 82.00% as of today's recent price of $62.20.

BEAT : 61.65 (+2.92%)
Zacks.com featured highlights include: Malibu Boats, BJ's, Group 1, Paycom and BioTelemetry

Zacks.com featured highlights include: Malibu Boats, BJ's, Group 1, Paycom and BioTelemetry

BJRI : 73.65 (+2.29%)
GPI : 71.94 (-1.92%)
MBUU : 53.84 (+1.70%)
BEAT : 61.65 (+2.92%)
PAYC : 157.69 (+0.18%)
Bet on These 5 Momentum Stocks Backed by Driehaus Strategy

We have used the Driehaus' "buy high and sell higher" principle to choose the best momentum stocks.

BJRI : 73.65 (+2.29%)
GPI : 71.94 (-1.92%)
MBUU : 53.84 (+1.70%)
BEAT : 61.65 (+2.92%)
PAYC : 157.69 (+0.18%)
Shares of BEAT Up 76.2% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Biotelemetry Inc (NASDAQ:BEAT) on April 16th, 2018 at $34.18. In approximately 5 months, Biotelemetry Inc has returned 76.15% as of today's recent price of $60.20.

BEAT : 61.65 (+2.92%)
Is BioTelemetry (BEAT) Outperforming Other Medical Stocks This Year?

Is (BEAT) Outperforming Other Medical Stocks This Year?

BEAT : 61.65 (+2.92%)
Innovative Diagnostic Technology Playing Significant Role in Improving Detection for Better Cardiac Care

PALM BEACH, Florida, September 5, 2018 /PRNewswire/ --

ZENO : 0.3121 (-5.42%)
BSX : 37.62 (+0.94%)
BEAT : 61.65 (+2.92%)
IRTC : 93.30 (+3.01%)
MNKD : 1.73 (+1.17%)
Here's Why BioTelemetry (BEAT) is a Great Momentum Stock

Does BioTelemetry (BEAT) have what it takes to be a top stock pick for momentum investors? Let's find out.

BEAT : 61.65 (+2.92%)
71.5% Return Seen to Date on SmarTrend Biotelemetry Inc Call (BEAT)

SmarTrend identified an Uptrend for Biotelemetry Inc (NASDAQ:BEAT) on April 16th, 2018 at $34.18. In approximately 5 months, Biotelemetry Inc has returned 71.47% as of today's recent price of $58.60.

BEAT : 61.65 (+2.92%)
Medical Services Boom Drives Healthcare: 3 Top Picks

Considering the rising popularity of PBM, CRO and EHR in the U.S. Medical Services industry, these three picks might be money-spinning choices for investors.

MEDP : 63.74 (+2.07%)
CERN : 64.38 (+0.28%)
CVS : 78.61 (+0.65%)
BEAT : 61.65 (+2.92%)
LH : 171.32 (+0.01%)
PRAH : 109.91 (+1.55%)
Biotelemetry Inc Up 68.7% Since SmarTrend Uptrend Call (BEAT)

SmarTrend identified an Uptrend for Biotelemetry Inc (NASDAQ:BEAT) on April 16th, 2018 at $34.18. In approximately 4 months, Biotelemetry Inc has returned 68.69% as of today's recent price of $57.65.

BEAT : 61.65 (+2.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade BEAT with:

Business Summary

BioTelemetry, Inc. provides ambulatory outpatient management solutions for monitoring clinical information regarding an individual's health. It is focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders. BioTelemetry, Inc., formerly known as CardioNet, Inc., is headquartered...

See More

Key Turning Points

2nd Resistance Point 63.58
1st Resistance Point 62.62
Last Price 61.65
1st Support Level 60.32
2nd Support Level 58.98

See More

52-Week High 62.80
Last Price 61.65
Fibonacci 61.8% 47.71
Fibonacci 50% 43.05
Fibonacci 38.2% 38.39
52-Week Low 23.30

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar